ALLO
Allogene Therapeutics, Inc. · Healthcare
Chief Financial Officer Geoffrey M. Parker sold $49K of Allogene Therapeutics, Inc.
Sold$48,698
$1.34Price
36,342Shares
−3%Stake
What ALLO did after the filing
Prices for ALLO after this filing aren't in yet.
Traded Wed, Oct 21. Filed Fri, Oct 23, 4:48 PM ET, after the close. Not investment advice.